RJF logo

RJF
Raymond James Financial, Inc.

600
Mkt Cap
$28.81B
Volume
918,249.00
52W High
$177.66
52W Low
$129.47
PE Ratio
14.31
RJF Fundamentals
Price
$146.19
Prev Close
$148.14
Open
$147.79
50D MA
$152.94
Beta
1.01
Avg. Volume
1.38M
EPS (Annual)
$10.30
P/B
2.31
Rev/Employee
$647,343.78
$26,425.16
Loading...
Loading...
News
all
press releases
Milestone Pharmaceuticals (NASDAQ:MIST) Upgraded to Strong-Buy at Raymond James Financial
Raymond James Financial raised Milestone Pharmaceuticals to a "strong-buy" rating in a research note on Thursday...
MarketBeat·14h ago
News Placeholder
More News
News Placeholder
Insmed (NASDAQ:INSM) Upgraded to "Moderate Buy" at Raymond James Financial
Raymond James Financial raised shares of Insmed to a "moderate buy" rating in a research report on Thursday...
MarketBeat·14h ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Upgraded to Strong-Buy at Raymond James Financial
Raymond James Financial raised Praxis Precision Medicines to a "strong-buy" rating in a report on Thursday...
MarketBeat·14h ago
News Placeholder
PTC Therapeutics (NASDAQ:PTCT) Stock Rating Upgraded by Raymond James Financial
Raymond James Financial upgraded PTC Therapeutics to a "moderate buy" rating in a research report on Thursday...
MarketBeat·14h ago
News Placeholder
Rapport Therapeutics (NASDAQ:RAPP) Upgraded by Raymond James Financial to Strong-Buy Rating
Raymond James Financial upgraded shares of Rapport Therapeutics to a "strong-buy" rating in a research report on Thursday...
MarketBeat·14h ago
News Placeholder
United Therapeutics (NASDAQ:UTHR) Stock Rating Upgraded by Raymond James Financial
Raymond James Financial raised United Therapeutics to a "moderate buy" rating in a research report on Thursday...
MarketBeat·14h ago
News Placeholder
Raymond James Financial Increases Firan Technology Group (TSE:FTG) Price Target to C$24.00
Raymond James Financial upped their price objective on Firan Technology Group from C$20.00 to C$24.00 and gave the stock an "outperform" rating in a report on Friday...
MarketBeat·1d ago
News Placeholder
Blackline Safety (TSE:BLN) Downgraded to "Market Perform" Rating by Raymond James Financial
Raymond James Financial lowered Blackline Safety from an "outperform" rating to a "market perform" rating and reduced their price objective for the company from C$10.00 to C$9.38 in a research note...
MarketBeat·1d ago
News Placeholder
Raymond James Financial Initiates Coverage on Praxis Precision Medicines (NASDAQ:PRAX)
Raymond James Financial began coverage on shares of Praxis Precision Medicines in a research note on Friday. They issued a "strong-buy" rating and a $815.00 price target on the stock...
MarketBeat·1d ago
News Placeholder
Raymond James Financial Initiates Coverage on Insmed (NASDAQ:INSM)
Raymond James Financial started coverage on Insmed in a research note on Friday. They issued an "outperform" rating and a $200.00 target price on the stock...
MarketBeat·1d ago
<
1
2
...
>

Latest RJF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.